Everyday Contacts
An affordable premium contact lens exclusively available from your Eye Doctor
Analytics
Raised to Date: $17,499
Aggregate Commitments $
Wefunder
02/17/2021
04/08/2021
$50,000
$250,000
$1,000
Equity - Preferred
RegCF
Seed
$7,370,000
Weekly Commitments $
Active
02/28/2021
37
35%
7%
$1,591
Albuquerque, New Mexico
Healthcare & Pharmaceuticals
HealthTech
B2B/B2C
Medium
High
Everyday Contacts, with a pre-money valuation of $7.37 million, is raising crowdfunding on Wefunder. The company is introducing premium contact lenses with comfort coating. The daily disposable lenses are coated with hydrophilic coating and are available exclusively from eye doctors. Lawrence Chavez founded Everyday Contacts in 2018. The proceeds of the current crowdfunding raise, with a minimum target of $50,000 and a maximum target of $250,000, will be used towards the clinical trial. Everyday Contacts has a scalable business model and expects to grow the business to $20 million in revenues in two years after the launch. The product development has been completed and is pending clinical trial and FDA approval.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$750 |
$4,880 |
|
COGS |
$0 |
$0 |
|
Tax |
$5,328 |
$0 |
| ||
| ||
|
Net Income |
$-609,802 |
$-447,337 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$323,942 |
$32,486 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$350,443 |
$55,633 |
|
Short-Term Debt |
$40,458 |
$41,769 |
|
Long-Term Debt |
$0 |
$0 |
|
Total Liabilities |
$40,458 |
$502,970 |
Ratings
Ratings Platform - Beta Trial
Our new ratings and analytics platform is currently in Beta. To gain access to the Beta platform features, upgrade to a Pro paid account and accept the Beta terms on any page.
For a limited time, use coupon code "TRYMERLIN20" for a free 20 day trial of Kingscrowd Pro and Merlin Beta. Your paid subscription will activate at the end of 20 days. Cancel anytime.Other Deals
MedVector on StartEngine
The COVID-19 pandemic has grown the telehealth industry exponentially. A recent study of U.S medical specialists found that
Phoenix PharmaLabs on Netcapital
In the years before the world’s current COVID-19 crisis, America in particular faced a deadly and persistent threat…
C-Reveal Therapeutics on NetCapital
Cancer is the great, mysterious killer of medical science. As of January 2019, there were an